Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients

Pathology International
Joon Seon SongSe Jin Jang

Abstract

Global histone modification patterns are presumed to establish epigenetic patterns of gene expression and determine the biology of the cell. In the present study, the global modification status of histone H3 and H4 was evaluated in 408 non-small cell lung cancer (NSCLC) tissues by immunostaining. NSCLC showed variable staining scores for each antibody. Clinicopathological analyses demonstrated a positive correlation between weak nuclear staining for H3K9Ac (P < 0.001), H3K9TriMe (P= 0.001), H4K16Ac (P < 0.001) and tumor recurrence except H4K20 TriMe (P= 0.201). Staining scores of four different antibodies were not correlated with other clinicopathologic variables. Patients were further clustered according to histone modification patterns: acetylation dominant, methylation dominant, co-dominant and modification-negative. The acetylation-dominant group (P= 0.009) and co-dominant group exhibited less frequent lymph node metastasis (P= 0.050), recurrence (P= 0.002) and distant metastasis (P= 0.010). The acetylation-dominant group showed better prognosis in survival analysis (P < 0.001, log-rank), whereas methylation-dominant and modification-negative status was associated with poor prognosis. In conclusion, our data suggest that gl...Continue Reading

References

Nov 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·K Marushige
Jul 3, 1989·FEBS Letters·A ProfumoG Vidali
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·S Y ArcherR A Hodin
Jul 14, 1998·Nature Medicine·J KononenO P Kallioniemi
May 14, 1999·Current Opinion in Genetics & Development·S Y Archer, R A Hodin
Jan 19, 2000·Nature·B D Strahl, C D Allis
Dec 2, 2000·Nature·M VogelauerM Grunstein
Jan 5, 2001·Laboratory Investigation; a Journal of Technical Methods and Pathology·R L CampD L Rimm
Mar 16, 2001·Breast Cancer Research : BCR·A C Phillips, K H Vousden
Apr 3, 2001·Frontiers in Bioscience : a Journal and Virtual Library·C WangR G Pestell
Jul 5, 2001·Cellular and Molecular Life Sciences : CMLS·S TimmermannA Harel-Bellan
Feb 13, 2002·Current Biology : CB·Jacqueline E MermoudNeil Brockdorff
Jun 4, 2002·Nature Reviews. Genetics·Peter A Jones, Stephen B Baylin
Oct 31, 2003·Trends in Genetics : TIG·Robert J SimsDanny Reinberg
Apr 10, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Daniel G RosenJinsong Liu
Apr 20, 2004·International Journal of Cancer. Journal International Du Cancer·Yasushi TohGarth L Nicolson
May 18, 2004·Genes & Development·Gunnar SchottaThomas Jenuwein
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hojoong KimDuk-Hwan Kim
Jul 23, 2004·Current Biology : CB·Craig L Peterson, Marc-André Laniel
Aug 26, 2004·Advances in Cancer Research·Paul A MarksWilliam Kevin Kelly
Oct 7, 2004·Genes & Development·Anders H Lund, Maarten van Lohuizen
Dec 18, 2004·Critical Reviews in Clinical Laboratory Sciences·Mukesh VermaSudhir Srivastava
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
May 18, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kapil N Bhalla
Jul 1, 2005·Nature·David B SeligsonSiavash K Kurdistani
Jun 27, 2007·British Journal of Cancer·S K Kurdistani
Oct 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fabrice BarlésiJose Antonio Rodriguez

❮ Previous
Next ❯

Citations

Nov 14, 2013·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Leah C Young, Michael J Hendzel
Dec 18, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mukesh VermaJohn P A Ioannidis
Jul 6, 2013·Epigenetics & Chromatin·Gary LeroyBenjamin A Garcia
Oct 15, 2013·Journal of Neurosurgery·Azadeh EbrahimiHermann Schluesener
Dec 4, 2012·International Journal of Molecular Sciences·Elena López, William C S Cho
Jul 23, 2013·International Journal of Molecular Sciences·Joong-Gook KimJoo Mi Yi
Nov 29, 2013·Archives of Pathology & Laboratory Medicine·Ronghui XiaJiang Li
Oct 30, 2015·Future Medicinal Chemistry·Juan BayoElisabeth D Martinez
Sep 20, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Dorothy Ngo-Yin FanChun-Ming Wong
Oct 2, 2012·Free Radical Biology & Medicine·Michael J Hitchler, Frederick E Domann
Jan 12, 2017·Cancers·Peter McAnenaMichael J Kerin
Mar 23, 2017·Histopathology·Liana P WebberManoela D Martins
Jan 12, 2017·Nucleic Acids Research·Laura CastelliniAmato J Giaccia
Sep 15, 2017·Clinical Epigenetics·Abril Marcela Herrera-SolorioFederico Ávila-Moreno
Nov 16, 2016·Epigenetics : Official Journal of the DNA Methylation Society·Insa SchiffmannMichael Lübbert
Jun 8, 2013·The Journal of Biological Chemistry·Leah C YoungMichael J Hendzel
Dec 14, 2018·Molecular Diagnosis & Therapy·Katarzyna KamińskaMarzena Anna Lewandowska
Oct 27, 2020·PloS One·Nebiyu A AbshiruNeil L Kelleher
Oct 15, 2020·Clinical Epigenetics·Theodore VougiouklakisVassiliki Saloura
Sep 10, 2020·Cold Spring Harbor Perspectives in Medicine·Yvonne L Chao, Chad V Pecot
May 26, 2021·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·T C FonsêcaA C Abrahão
Sep 25, 2020·Pathology, Research and Practice·Juliana Moreira De Almeida Sant'AnaPaulo Rogério de Faria
Jul 18, 2021·Oral Diseases·Felipe Martins SilveiraManoela Domingues Martins

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.